Taro Pharmaceutical Industries Stock Today
| TARO Stock | USD 42.24 0.19 0.45% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Taro Pharmaceutical is selling at 42.24 as of the 18th of April 2024; that is 0.45% increase since the beginning of the trading day. The stock's open price was 42.05. Taro Pharmaceutical has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Taro Pharmaceutical Industries are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of October 2022 and ending today, the 18th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of April 1993 | Category Healthcare | Classification Health Care |
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. Taro Pharmaceutical Industries Ltd. The company has 37.58 M outstanding shares of which 39.81 K shares are at this time shorted by private and institutional investors with about 0.88 trading days to cover. More on Taro Pharmaceutical Industries
Follow Valuation Options Odds of Bankruptcy
Report 28th of May 2024
Taro Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Taro Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Taro Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Uday Baldota | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Obamacare, Israel Wall Street, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Taro Pharmaceutical report their recommendations after researching Taro Pharmaceutical's financial statements, talking to executives and customers, or listening in on Taro Pharmaceutical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Taro Pharmaceutical. The Taro consensus assessment is calculated by taking the average forecast from all of the analysts covering Taro Pharmaceutical. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Taro Pharmaceutical's profitability, liquidity, and operating efficiency, Taro Pharmaceutical Industries is doing better financially then in previous quarter. It has a moderate probability of reporting better financial numbers in May. Financial strength of Taro Pharmaceutical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taro Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Taro Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Taro Pharmaceutical's financial leverage. It provides some insight into what part of Taro Pharmaceutical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Taro Pharmaceutical Industries (TARO) is traded on New York Stock Exchange in USA. It is located in 14 Hakitor Street, Haifa, Israel, 2624761 and employs 1,554 people. Taro Pharmaceutical is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taro Pharmaceutical's market, we take the total number of its shares issued and multiply it by Taro Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Taro Pharmaceutical conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 37.58 M outstanding shares of which 39.81 K shares are at this time shorted by private and institutional investors with about 0.88 trading days to cover.
Taro Pharmaceutical Industries currently holds about 806.25 M in cash with 31.75 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.45.
Check Taro Pharmaceutical Probability Of Bankruptcy
Ownership AllocationTaro Pharmaceutical maintains a total of 37.58 Million outstanding shares. Taro Pharmaceutical has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 78.48 % of Taro Pharmaceutical outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Taro Ownership Details
Taro Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Taro Pharmaceutical jumping above the current price in 90 days from now is about 47.15%. The Taro Pharmaceutical Industries probability density function shows the probability of Taro Pharmaceutical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Taro Pharmaceutical has a beta of 0.2659. This usually implies as returns on the market go up, Taro Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Taro Pharmaceutical Industries will be expected to be much smaller as well. Additionally, taro Pharmaceutical Industries has an alpha of 0.0096, implying that it can generate a 0.00957 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Taro Pharmaceutical to move above the current price in 90 days from now is about 47.15 (This Taro Pharmaceutical Industries probability density function shows the probability of Taro Stock to fall within a particular range of prices over 90 days) .
Taro Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Taro Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Taro Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Taro Pharmaceutical's value.| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2023-12-31 | 62.1 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 56.4 K | |
| Ark Investment Management Llc | 2023-12-31 | 55.3 K | |
| Vanguard Group Inc | 2023-12-31 | 50.8 K | |
| Norges Bank | 2023-12-31 | 42.8 K | |
| Arrowstreet Capital Limited Partnership | 2023-12-31 | 39.6 K | |
| Ubs Group Ag | 2023-12-31 | 36.9 K | |
| Nuveen Asset Management, Llc | 2023-12-31 | 34.5 K | |
| Citadel Advisors Llc | 2023-09-30 | 22.7 K | |
| Krensavage Asset Management, Llc | 2023-12-31 | 646.5 K | |
| Blackrock Inc | 2023-12-31 | 623 K |
Taro Pharmaceutical Historical Income Statement
Taro Pharmaceutical Industries Income Statement is one of the three primary financial statements used for reporting Taro's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Taro Pharmaceutical revenue and expense. Taro Pharmaceutical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Taro Pharmaceutical reported last year Minority Interest of (904,000). As of the 18th of April 2024, Selling And Marketing Expenses is likely to grow to about 136.8 M, while Total Revenue is likely to drop about 356.7 M. View More FundamentalsTaro Stock Against Markets
Picking the right benchmark for Taro Pharmaceutical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Taro Pharmaceutical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Taro Pharmaceutical is critical whether you are bullish or bearish towards Taro Pharmaceutical Industries at a given time. Please also check how Taro Pharmaceutical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Taro Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Taro Pharmaceutical Corporate Directors
Taro Pharmaceutical corporate directors refer to members of a Taro Pharmaceutical board of directors. The board of directors generally takes responsibility for the Taro Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Taro Pharmaceutical's board members must vote for the resolution. The Taro Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Jeff Holm | Executive Director Sales and Operations of Branded Pharmaceutical business | Profile | |
| Ralph Bohrer | Executive Director, Sales and Marketing, TPHA | Profile | |
| Danny Biran | Independent Director | Profile | |
| Ilana AvidovMor | Independent Director | Profile |
How to buy Taro Stock?
Before investing in Taro Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Taro Pharmaceutical. To buy Taro Pharmaceutical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Taro Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Taro Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Taro Pharmaceutical Industries stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Taro Pharmaceutical Industries stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Taro Pharmaceutical Industries, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Taro Stock please use our How to Invest in Taro Pharmaceutical guide.
Already Invested in Taro Pharmaceutical Industries?
The danger of trading Taro Pharmaceutical Industries is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Taro Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Taro Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Taro Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Taro Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Taro Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Taro Pharmaceutical Industries Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Taro Pharmaceutical Industries Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Taro Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Taro Stock analysis
When running Taro Pharmaceutical's price analysis, check to measure Taro Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taro Pharmaceutical is operating at the current time. Most of Taro Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Taro Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taro Pharmaceutical's price. Additionally, you may evaluate how the addition of Taro Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Taro Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Taro Pharmaceutical. If investors know Taro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Taro Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.782 | Earnings Share 1.22 | Revenue Per Share 16.252 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0103 |
The market value of Taro Pharmaceutical is measured differently than its book value, which is the value of Taro that is recorded on the company's balance sheet. Investors also form their own opinion of Taro Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Taro Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Taro Pharmaceutical's market value can be influenced by many factors that don't directly affect Taro Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Taro Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Taro Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Taro Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.